Article
Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.
The New England journal of medicine - 12 Feb 2009
Hütter Gero, Nowak Daniel, Mossner Maximilian, Ganepola Susanne, Müssig Arne, Allers Kristina, Schneider Thomas, Hofmann Jörg, Kücherer Claudia, Blau Olga, Blau Igor W, Hofmann Wolf K, Thiel Eckhard
Abstract excerpt
Infection with the human immunodeficiency virus type 1 (HIV-1) requires the presence of a CD4 receptor and a chemokine receptor, principally chemokine receptor 5 (CCR5). Homozygosity for a 32-bp deletion in the CCR5 allele provides resistance against HIV-1 acquisition. We transplanted stem cells from a donor who was homozygous for CCR5 delta32 in a patient with acute myeloid leukemia and HIV-1 infection. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
